- Product Partners
- Supplements Facts
- Scientific References
- Client Reviews
Your Prostate Supplement Should Contain Nutrients Tested Using the
Gold Standard Index for Prostate and Urinary Health…
Prostate Protector™ is formulated for men over age 40 to support prostate and urinary health.
Prostate Protector™ incorporates the latest findings in prostate and urinary health - and excludes some ingredients that recent research suggests aren’t worth your money.
The first key ingredient is a cranberry extract called Flowens®, which in a recent clinical study was found to reduce symptoms of benign prostatic hyperplasia (BPH) by 44% over six months. This was measured by using the gold standard index for prostate and urinary health - The International Prostate Symptom Score or IPSS.
Prostate Protector™ also has a premium pumpkin seed extract called EFLA® 940. In one study, EFLA® 940 helped reduce nocturnal (nighttime) urination frequency by almost 40% after six weeks.
It also contain a natural source of beta sitosterol from North Carolina pine trees. In numerous clinical studies, beta sitosterol has been show to improve IPSS scores by as much as 50%.
Prostate Protector™ also contains SelenoExcell® - which is made from high selenium yeast - and was recently shown to protect the prostate from oxidative stress. For futher free radical protection, the formula includes a green tea extract rich in EGCG, zinc (from TRAACS® as bisglycinate chelate).
Flowens®: 44% Improvement in Prostate Health and Urinary Symptoms
For over a decade, NatureCity® has used a cranberry ingredient called PACran® in our AloeCran drink mix product - one of our most popular items.
So a few years ago when the makers of PACran® presented to us a clinical study indicating dramatic benefits in prostate and urinary health - we were really excited. The only challenge was the study used a fairly large daily dose - about 1,500mg of PACran®.
Our supplier went back to the drawing board, and developed a more concentrated cranberry ingredient for prostate health called Flowens®.
Flowens® has been shown to work when taking as little as 250mg a day - and works even better at 500mg a day, which is the amount you get in Prostate Protector™.
The specific benefits of Flowensr were recently demonstrated in a 124 person placebo controlled clinical study conducted by researchers from Palecky University in the Czech Republic. All of the men is this study were coping with symptoms of benign prostatic hyperplasia (BPH).
During the study, the men were evaluated using several measures, including the gold standard index for prostate and urinary health - The International Prostate Symptom Score or IPSS.
IPSS measures seven symptoms linked to BPH - urinary frequency, bladder emptying, intermittency, urgency, weak stream, straining and nocturnia (having to urinate frequently at night).
The men in the study took one of the following each day for 6 months - (i) placebo, (ii) 250mg of Flowensr, or (iii) 500mg of Flowens®. Here is how each group fared using the IPSS score at the end of the six month study:
Many men take saw palmetto for prostate health, but the truth is it has never been shown to be effective on the IPSS scale for any extended period of time. Moreover, the most recent clinical studies indicate saw palmetto is no more effective than a placebo - even at double and triple the recommended dose!
With Flowens®, you finally have a reliable ingredient to address the urinary symptoms of BPH - and without any unwanted reported side effects. Another remarkable finding from the clinical study is about 97% of Flowens® users would recommend it to a friend - that's almost every man who tried it. Plus, men reported benefits started after just three weeks of use.
EFLA® 940 Pumpkin Seed: 40% Reduction in Nighttime Urination
Pumpkin seeds have a long history of being used for prostate and urinary problems. Native to North America, Native American tribes used pumpkin seeds to help with "passage of urine."
They passed along this knowledge to European explorers and in the year 1578, pumpkin seeds were first listed in the European herbal encyclopedia to help urinary problems.
Modern science has begun to unlock the secrets about how pumpkin seeds work.
For starters, pumpkin seeds help inhibit the enzyme, 5-alpha reductase, which converts testosterone to dihydrotestosterone (DHT).
Numerous studies have indicated that excessive DHT is a major cause of many prostate problems. By helping to keep control 5-alpha reductase, pumpkin seeds help keep DHT and testosterone levels balanced.
As important, pumpkin seeds also have been shown to inhibit the conversion of testosterone to estrogen - by blocking the enzyme aromatase. Failing to do so (like some other prostate products), could lead to a decrease in sexual function and desire.
In Prostate Protector™, you'll find a premium, clinically tested pumpkin seed extract called EFLA® 940.
According to a clinical study published in the Japanese Journal of Medicine and Pharmaceutical Science, you may start experiencing benefits from EFLA® 940 in as little as two weeks.
This study of 45 males over age 65 looked at the ability of EFLA® 940 to help with nocturnal (nighttime) urination, a common age related issue in men and those with BPH.
After just two weeks, the frequency of nocturnal urination declined by about 25% , on average - and at the end of the six week study, nocturnal urination frequency declined by almost 40%.
All in, over 86% of the men taking EFLA® 940 reported that their symptoms improved during the study.
And since these men didn't have to urinate as frequently, most reported increased sleep satisfaction after taking EFLA® 940.
Prostate Protector™ contains the same 500mg serving of EFLA® 940 used in this and other clinical studies.
Beta Sitosterol from North Carolina Pine Trees
The plant phytosterol known as beta sitosterol has been shown to both help relieve symptoms of BPH and promote a healthier prostate through reduced swelling.
The scientific evidence demonstrating these benefits used a natural source of beta sitosterol. Unfortunately, many prostate products now use a cheaper synthetic source of beta sitosterol - but not Prostate Protector™.
Each serving includes 70mg of a natural source of beta sitosterol which is extracted from the oil of North Carolina pine trees.
Over two dozen studies have demonstrated the benefits of natural beta sitosterol on prostate health and BPH. The one considered the best was conducted by scientists at the University of Bochum in Germany, and published in the prestigious journal, The Lancet.
The 200 men in this study took either 60mg of natural beta sitosterol daily for 6 months or a placebo. The group taking the placebo did not experience an improvement.
On the other hand, the men taking beta sitosterol experienced about a 50% decline in IPSS scores, and a reduction in prostate volume. On average, they improved significantly on all seven urinary flow parts of the IPSS score.
Even better, many men continued taking beta sitosterol for a total of 18 months and all the benefits were maintained for the entire period.
Still better, men originally in the placebo group also started taking beta sitosterol and over time improved like the others.
How does it work? Research at the University of Rome indicated that beta sitosterol lowers DHT in the prostate by reducing the binding of DHT to tissue - as opposed to inhibiting DHT's production (so it complements the action of the EFLA® 940 pumpkin seed).
In addition, other studies using a 130mg daily serving of beta sitosterol haven't recorded markedly better results than the 60mg serving - so the 70mg in Prostate Protector™ should deliver exactly what's needed.
Why the Type of Selenium in Your Prostate Supplement Matters.
When it comes to prostate supplements, one of the most confusing and least understood aspects is the role of the mineral selenium.
Back around 1998 there was great excitement about selenium's ability to influence prostate health.
The results of clinical trials published in two renowned medical journals - the Journal of the American Medical Association (JAMA) and the British Journal of Urology - showed remarkable prostate benefits.
One of the unique features of SelenoExcell® is it's not a single selenium compound, it's a cluster of multiple selenium compounds bound to different amino acids - which is the way your body gets selenium from food.
For example, SelenoExcell® naturally includes selenomethionine, selenocysteine and methylselenocysteine and other forms of selenium.
So you would think SelenoExcell® would become the standard for future prostate research - but just the opposite happened.
In a government sponsored $300 million trial (the "SELECT Trial" which was to examine the effects of taking vitamin E and selenium on the prostate) - they decided to not use SelenoExcell®.
Instead they choose a synthetic source of just one form of selenium - selenomethionine, which is found in many supplements.
At the time, the makers of SelenoExcell® were screaming loudly to anyone who would listen that the SELECT Trial was likely doomed to fail for two reasons: 1) SelenoExcell® is much more than selenomethionine, and 2) the selenomethionine form being used never had been shown to be protective of the prostate - even in animal studies.
And sure enough, the folks from SelenoExcell® were spot-on correct - in the SELECT Trial, there were no prostate benefits in men taking selenomethionine.
This was a shame for many reasons - most notably, because the headlines from the general news media proclaimed that "selenium" wasn't beneficial to prostate health. As you now know, this isn't true - the work done with SelenoExcell® showed it was quite beneficial!
More recent research has reinforced the benefits of SelenoExcell® on prostate health.
For example, just recently researchers at Penn State performed a head-to-head test of SelenoExcell® versus selenomethionine. In this study, SelenoExcell® was found to protect the prostate from oxidative stress caused by free radicals - while selenomethionine had no impact.
On top of this, another recent study published in Environmental Science Technology, showed SelenoExcell® helps rid the body of unwanted heavy metals like mercury and cadmium. In this study, the urinary excretion of mercury increased by 175% in those taking SelenoExcell® for three months.
Each serving of Prostate Protector™ provides 100mcg of SelenoExcell® - which supplements the estimated 100mcg of dietary selenium consumed by the average person in a day.
Where in the Body is the Largest Concentration of Zinc?
Dietary Supplement / 90 capsules
Serving Size: 3 capsules
Servings per Container: 30
|Amount Per Serving||% Daily Value|
|Vitamin D [as Vitamin D3 (cholecalciferol)]||400 IU||100%|
|Zinc (from TRAACS® as bisglycinate chelate)||15 mg||100%|
|Selenium (as SelenoExcell® organically bound high selenium yeast)||100 mcg||143%|
|Pumpkin seed extract (EFLA®940)||500 mg||*|
|Cranberry proprietary blend (Flowens™)||500 mg||*|
|Beta sitosterol [from pine phytosterols]||70 mg||*|
|Green tea leaf standardized extract (98% polyphenols, 45% EGCG)||225 mg||*|
* Daily value not established.
Other ingredients: Gelatin, rice flour, silica, vegetable magnesium stearate
Flowens™ is a trademark of Naturex.
EFLA® 940 is a trademark of Frutarom Switzerland.
Phytopin® is a trademark of DRT.
TRAACS® is a registered trademark of Albion Laboratories, Inc.
SelenoExcell® is a registered trademark of Cypress Systems, Inc.
NatureCity®'s Prostate Protector™ is specially formulated to help maintain normal prostate function & urinary health.†
SUGGESTED USE: Take three (3) capsules daily as a dietary supplement.
Keep out of reach of children.
Store at 15-30° C (59-86° F).
Protect from heat, light and moisture.
Do not purchase if seal is broken.
†These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.
- Gluten Free
- Assembled in the USA
Manufactured for and Distributed by: NatureCity®
Boca Raton, FL 33487 www.naturecity.com
To re-order call toll free 1-800-593-2563
Flowens™ Cranberry Powder
Student V, Vostalova J, Vidlar A, Klejdus B, Fromentin E, Roller M, Simanek V. “Cranberry fruit powder (FlowensTM) improves lower urinary tract symptoms in men: A double-blind, randomized, placebo controlled study.”
Vidlar A, Vostalova J, Ulrichova J, Student V, Stejskal D, Reichenbach R, Vrbkova J, Ruzicka F, Simanek V. “The effectiveness of dried cranberries ( Vaccinium macrocarpon) in men with lower urinary tract symptoms.” British Journal of Nutrition. 2010 Oct;104(8):1181-9.
Nishimura M, Ohkawara T, Sato H, Takeda H, Nishihira J. Pumpkin Seed Oil Extracted From Cucurbita maxima Improves Urinary Disorder in Human Overactive Bladder. Journal of Traditional and Complementary Medicine. 2014;4(1):72-74. doi:10.4103/2225-4110.124355.
Cho YH, Lee SY, Jeong DW, et al. Effect of Pumpkin Seed Oil on Hair Growth in Men with Androgenetic Alopecia: A Randomized, Double-Blind, Placebo-Controlled Trial. Evidence-based Complementary and Alternative Medicine?: eCAM. 2014;2014:549721. doi:10.1155/2014/549721.
Yadav M, Jain S, Tomar R, Prasad G, Yadav H. “Medicinal and biological potential of pumpkin: an updated review.” Nutrition Research Reviews. December 2010. Volume 23, pp 184190.
Hong H, Kim C, Maeng S. “Effects of pumpkin seed oil and saw palmetto oil in Korean men with symptomatic benign prostatic hyperplasia.” Nutrition Research and Practice. 2009 Winter; 3(4): 323–327.
Terado T, Sogabe H. “Clinical study of mixed processed foods containing pumpkin seed on pollakiuria in night in elder men.” Japanese Journal of Medicine and Pharmaceutical Science. 2004;52(4):551-561.
Yanagisawa Ei et al. “Effects of EFLA®940/Soybean germ extract combination on stress urinary incontinence in an open clinical study.” Japanese Journal of Medicine and Pharmaceutical Science. 2003 Vol 50 (3).
Bach D. Placebo-controlled, long-term therapeutic study of a pumpkin seed extract product in patients with micturition complaints from benign prostatic hyperplasia. Urologe B. 2000;40:437–443.
McNicholas T, Kirby R. Benign prostatic hyperplasia and male lower urinary tract symptoms (LUTS). BMJ Clinical Evidence. 2011;2011:1801.
Coleman CI, Hebert JH, Reddy P. “The effect of phytosterols on quality of life in the treatment of benign prostatic hyperplasia.” Pharmacotherapy. 2002 Nov;22(11):1426-32.
Preuss HG, Marcusen C, Regan J, Klimberg IW, Welebir TA, Jones WA. “Randomized trial of a combination of natural products (cernitin, saw palmetto, B-sitosterol, vitamin E) on symptoms of benign prostatic hyperplasia (BPH).” International Journal of Urology and Nephrology. 2001;33(2):217-25.
Awad AB, Fink CS. “Phytosterols as anticancer dietary components: evidence and mechanism of action.” Journal of Nutrition. 2000 Sep;130(9):2127-30.
Berges RR, Kassen A, Senge T. “Treatment of symptomatic benign prostatic hyperplasia with beta-sitosterol: an 18-month follow-up.” British Journal of Urology International. 2000 May;85(7):842-6. PMID 10792163.
Wilt T, Ishani A, MacDonald R, Stark G, Mulrow C, Lau J. “β-sitosterol for the treatment of benign prostatic hyperplasia:a systematic review.” BJU International. 1999. 83, 976-983.
Klippel K, Hiltl D, Schipp B. “A multicentric, placebo-controlled, double-blind clinical trial of & beta;-sitosterol (phytosterol) for the treatment of benign prostatic hyperplasia.” British Journal of Urology. September, 1997. Volume 80, Issue 3, 427-432.
Berges RR, Windeler J, Trampisch HJ, Senge T. “Randomised, placebo-controlled, double-blind clinical trial of beta-sitosterol in patients with benign prostatic hyperplasia. Beta-sitosterol Study Group.” The Lancet. 1995 Jun 17;345(8964):1529-32.
Fischer A, Jurincic Winkler CD, Klippel KF. Conservative treatment of benign prostatic hyperplasia with high dosage beta- sitosterol (65 mg): results of a placebo-controlled double blind study. Uroscop 1993; 1: 12±20.
Goodarzi D, Cyrus A, Baghinia MR, Kazemifar AM, Shirincar M. “The efficacy of zinc for treatment of chronic prostatitis.” Acta Med Indones. 2013 Oct;45(4):259-64.
Christudoss P, Selvakumar R, Fleming J, Gopalakrishnan G. “Zinc status of patients with benign prostatic hyperplasia and prostate carcinoma.” Indian Journal of Urology. 2011 Jan-Mar; 27(1): 14–18.
Yan M, Hardin K, Ho E. “Differential response to zinc-induced apoptosis in benign prostate hyperplasia and prostate cancer cells.” The Journal of Nutritional Biochemistry. 2010 Aug; 21(8): 687–694.
Ho E1, Song Y. “Zinc and prostatic cancer.” Current Opinion in Clinical Nutrition and Metabolic Care. 2009 Nov;12(6):640-5.
Gonzalez A, Peters U, Lampe JW, White E. “Zinc intake from supplements and diet and prostate cancer.” Nutrition and Cancer. March, 2009;61(2):206-15.
Gómez Y, Arocha F, Espinoza F, Fernández D, Vásquez A, Granadillo V. “Zinc levels in prostatic fluid of patients with prostate pathologies.” The Journal of Clinical Investigation. 2007 Sep;48(3):287-94.
Franklin RB, Costello LC. “Zinc as an anti-tumor agent in prostate cancer and in other cancers.” Archives of Biochemistry and Biophysics. 2007 Jul 15;463(2):211-7.
Zaichick VYe, Sviridova TV, Zaichick SV. “Zinc in the human prostate gland: normal, hyperplastic and cancerous.” International Journal of Urology and Nephrology. 1997;29(5):565-74.
Richie JP Jr, Das A, Calcagnotto AM, Sinha R, Neidig W, Liao J, Lengerich EJ, Berg A, Hartman TJ, Ciccarella A, Baker A, Kaag MG, Goodin S, DiPaola RS, El-Bayoumy K. “Comparative Effects of Two Different Forms of Selenium on Oxidative Stress Biomarkers in Healthy Men: A Randomized Clinical Trial” Cancer Prev Res August 1, 2014 7:796-804
Waters DJ, Shen S, Kengeri SS, et al. “Prostatic response to supranutritional selenium supplementation: comparison of the target tissue potency of selenomethionine vs. selenium-yeast on markers of prostatic homeostasis.” Nutrients 2012; 4(11):1650-63. doi: 10.3390/nu4111650.
Algotar, A. M., Stratton, M. S., Ahmann, Frederick. R., Ranger-Moore, J., Nagle, R. B., Thompson, P. A., Slate, E., Hsu, C. H., Dalkin, B. L., Sindhwani, P., Holmes, M. A., Tuckey, J. A., Graham, David. L., Parnes, H. L., Clark, L. C. and Stratton, S. P. (2013), “Phase 3 clinical trial investigating the effect of selenium supplementation in men at high-risk for prostate cancer.” Prostate, 73: 328–335.
Li, Zeqin Dong, Chunying Chen, Bai Li, Yuxi Gao, Liya Qu, Tianchen Wang, Xin Fu, Yuliang Zhao, and Zhifang Chai “Organic Selenium Supplementation Increases Mercury Excretion and Decreases Oxidative Damage in Long-Term Mercury-Exposed Residents from Wanshan, China” Environmental Science & Technology 2012 46 (20), 11313-11318
Facompre,N, El-Bayoumy K. “Potential Stages for Prostate Cancer Prevention with Selenium: Implications for Cancer Survivors.” Cancer Research. April 1, 2009 69; 2699.
El-Bayoumy K, Sinha R. “Molecular chemoprevention by selenium: a genomic approach.” Mutation Research. 2005; 591(1-2):224-36.
Duffield-Lillico AJ, Dalkin BL, Reid ME, et al. “Selenium supplementation, baseline plasma selenium status and incidence of prostate cancer: an analysis of the complete treatment period of the Nutritional Prevention of Cancer Trial.” British Journal of Urology International. 2003;91(7):608-12.
El-Bayoumy K, Richie JP Jr, Boyiri T, Komninou D, Prokopczyk B, Trushin N, Kleinman W, Cox J, Pittman B, Colosimo S. “Influence of selenium-enriched yeast supplementation on biomarkers of oxidative damage and hormone status in healthy adult males: a clinical pilot study.” Cancer Epidemiol Biomarkers Prev. 2002 Nov;11(11):1459-65.
Clark LC, Dalkin B, Krongrad A, Combs GF Hr,, Turnbull BW, Slate EH, Witherington R, Herlong J, Janosko E, Carpenter D, Borosso C, Falk S, Rounder J. “Decreased incidence of prostate cancer with selenium supplementation: results of a double-blind cancer prevention trial.” British Journal of Urology International. May, 1998. Volume 81, Issue 5, pages 730–734.
Clark LC, Combs GF Jr, Turnbull BW, Slate EH, Chalker DK, Chow J, Davis LS, Glover RA, Graham GF, Gross EG, Krongrad A, Lesher JL Jr, Park HK, Sanders BB Jr, Smith CL, Taylor JR. “Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group.” The Journal of the American Medical Association. 1996 Dec 25;276(24):1957-63.
Kumar NB, Pow-Sang J, Egan KM, Spiess PE, Dickinson S, Salup R, Helal M, McLarty JW, et AL. “Randomized, Placebo-Controlled Trial of Green Tea Catechins for Prostate Cancer Prevention.” Cancer Prev Res (Phila). 2015 Apr 14.
Henning SM, Wang P, Said JW, Huang M, Grogan T, Elashoff D, Carpenter CL, Heber D, Aronson WJ. “Randomized clinical trial of brewed green and black tea in men with prostate cancer prior to prostatectomy.” Prostate. 2015 Apr 1;75(5):550-9.
Zheng J, Yang B, Huang T, Yu Y, Yang J, Li D. “Green tea and black tea consumption and prostate cancer risk: an exploratory meta-analysis of observational studies.” Nutrition and Cancer. 2011;63(5):663-72
Butt MS, Sultan MT. “Green tea: nature's defense against malignancies.” Critical Reviews in Food Science and Nutrition. 2009 May;49(5):463-73.
Kurahashi N, Sasazuki S, Iwasaki M, Inoue M, Tsugane S. “Green tea consumption and prostate cancer risk in Japanese men: a prospective study.” American Journal of Epidemiology. 2008 Jan 1;167(1):71-7.
Brausi M, Rizzi F, Bettuzzi S. “Chemoprevention of human prostate cancer by green tea catechins: two years later. A follow-up update.” Eur Urol. 2008;54:472–473.
Bettuzzi S, Brausi M, Rizzi F, Castagnetti G, Peracchia G, Corti A. “Chemoprevention of Human Prostate Cancer by Oral Administration of Green Tea Catechins in Volunteers with High-Grade Prostate Intraepithelial Neoplasia: A Preliminary Report from a One-Year Proof-of-Principle Study.” Cancer Research. 2006 Jan 15;66(2):1234-40.
Jian L, Xie LP, Lee AH, Binns CW. “Protective effect of green tea against prostate cancer: a case-control study in southeast China.” International Journal of Cancer. 2004 Jan 1;108(1):130-5.
Jain MG, Hislop GT, Howe GR, Burch JD, Ghadirian P. “Alcohol and other beverage use and prostate cancer risk among Canadian men.” International Journal of Cancer. 1998 Dec 9;78(6):707-11.
Wieczorek K, Braczkowski RS, Skrzypek M, Stryjewski PJ, Kuczaj A, Al-Srory G. “The comparison between vitamin d concentration in upper silesia patients with prostate cancer and with benign prostatic hyperplasia.” J Biol Regul Homeost Agents. 2015 Jan-Mar;29(1):207-11.
Yalçnkaya S, Eren E2, Eroglu M1, Aydin O3, Yilmaz N3. “Deficiency of vitamin D and elevated aldosterone in prostate hyperplasia.” Advances in Clinical and Experimental Medicine. 2014 May-Jun;23(3):441-6.
Espinosa G, Esposito R, Kazzazi A, Djavan B. “Vitamin D and benign prostatic hyperplasia -- a review.” The Canadian Journal of Urology. 2013 Aug;20(4):6820-5.
Haghsheno MA, Mellström D, Behre CJ, Damber JE, Johansson H, Karlsson M, Lorentzon M, Peeker R, Barret-Connor E, Waern E, Sundh V, Ohlsson C, Hammarsten J. “Low 25-OH vitamin D is associated with benign prostatic hyperplasia.” The Journal of Urology. 2013 Aug;190(2):608-14.
Gilbert R, Metcalfe C, Oliver SE, Whiteman DC, Bain C, Ness A, et al. Life course sun exposure and risk of prostate cancer: population-based nested case-control study and meta-analysis. Int J Cancer. 2009;125:1414–23
Garland CF, Garland FC, Gorham ED, Lipkin M, Newmark H, Mohr SB, Holick MF. “The role of vitamin D in cancer prevention.” American Journal of Public Health. 2006 Feb;96(2):252-61.
Tuohimaa P, Tenkanen L, Ahonen M, Lumme S, Jellum E, Hallmans G, et al. Both high and low levels of blood vitamin D are associated with a higher prostate cancer risk: a longitudinal, nested case-control study in the Nordic countries. Int J Cancer. 2004;108:104–8.
Ahonen M, Tenkanen L, Teppo L, Hakama M, Tuohimaa P. “Prostate cancer risk and prediagnostic serum 25-hydroxyvitamin D levels (Finland).” Cancer Causes & Control. November 2000, Volume 11, Issue 9, pp 847-852.